{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:54:54Z","timestamp":1785203694743,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Secondary adrenal insufficiency is a frequent issue in patients with renal replacement therapy. There are concerns about metabolism and clearance for adrenocorticotropic hormone (ACTH) and cortisol in addition to hemoconcentration as confounding factors during hemodialysis (HD). Therefore, ACTH testing is currently performed before or in between HD sessions. This review of the literature aims to evaluate the current evidence for validity of testing for adrenal insufficiency in patients on chronic renal replacement therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A literature search of PubMed database for interventional and observational clinical trials was performed. Case reports and reviews were excluded. The search included all articles published until July 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 218 potentially eligible articles, 16 studies involving 381 participants were included. Seven studies performed an ACTH test before HD or in between HD sessions. There was no data available regarding ACTH testing during HD. But there was evidence of decreased cortisol levels during HD as compared to afterwards. All included 16 studies measured basal cortisol, and seven studies performed an ACTH test. Seven trials had comparable data of baseline cortisol for a quantitative analysis. Standardized mean difference of overall cortisol was 0.18\u2009nmol\/l (95%CI \u2212\u20090.08 to 0.44) in the case group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In patients undergoing renal replacement therapy, basal serum cortisol values are comparable to healthy volunteers. There is limited data on the validity of stimulated cortisol in these patients, especially during HD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Registration no. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/\">CRD42020199245<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02541-5","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T16:02:45Z","timestamp":1635782565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adrenal function testing in dialysis patients \u2013 a review of the literature"],"prefix":"10.1186","volume":"22","author":[{"given":"Lara","family":"Brotzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Nickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"issue":"3","key":"2541_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","volume":"3","author":"I Bancos","year":"2015","unstructured":"Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diab Endocrinol. 2015;3(3):216\u201326.","journal-title":"Lancet Diab Endocrinol"},{"issue":"9473","key":"2541_CR2","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(05)66583-X","volume":"365","author":"SJ Chadban","year":"2005","unstructured":"Chadban SJ, Atkins RC. Glomerulonephritis. Lancet. 2005;365(9473):1797\u2013806.","journal-title":"Lancet"},{"issue":"16","key":"2541_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJM199610173351607","volume":"335","author":"W Oelkers","year":"1996","unstructured":"Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335(16):1206\u201312.","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"2541_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/nep.13471","volume":"23","author":"Y Tomino","year":"2018","unstructured":"Tomino Y. How to treat patients with chronic kidney disease: with special focus on IgA nephropathy. Nephrology (Carlton). 2018;23(Suppl 4):76\u20139.","journal-title":"Nephrology (Carlton)"},{"issue":"10075","key":"2541_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352.","journal-title":"Lancet."},{"issue":"12","key":"2541_CR6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/ndt\/gfz180","volume":"35","author":"A Valentin","year":"2020","unstructured":"Valentin A, Borresen SW, Rix M, Elung-Jensen T, Sorensen SS, Feldt-Rasmussen U. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study. Nephrology Dial Transpl. 2020;35(12):2191\u20137.","journal-title":"Nephrology Dial Transpl"},{"issue":"3","key":"2541_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1755-6686.2013.12022.x","volume":"39","author":"H Almutary","year":"2013","unstructured":"Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care. 2013;39(3):140\u201350.","journal-title":"J Ren Care"},{"issue":"1","key":"2541_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","volume":"14","author":"FE Murtagh","year":"2007","unstructured":"Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82\u201399.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2541_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.steroids.2014.03.008","volume":"84","author":"AL Arregger","year":"2014","unstructured":"Arregger AL, Cardoso EM, Zucchini A, Aguirre EC, Elbert A, Contreras LN. Adrenocortical function in hypotensive patients with end stage renal disease. Steroids. 2014;84:57\u201363.","journal-title":"Steroids."},{"issue":"6","key":"2541_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","volume":"339","author":"B Bleicken","year":"2010","unstructured":"Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci. 2010;339(6):525\u201331.","journal-title":"Am J Med Sci"},{"key":"2541_CR11","doi-asserted-by":"publisher","first-page":"204201881984821","DOI":"10.1177\/2042018819848218","volume":"10","author":"R Dineen","year":"2019","unstructured":"Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients. Ther Adv Endocrinol Metab. 2019;10:2042018819848218.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"2541_CR12","first-page":"838","volume":"84","author":"TA Abdu","year":"1999","unstructured":"Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999;84(3):838\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2541_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1210\/jcem-33-1-14","volume":"33","author":"ED Weitzman","year":"1971","unstructured":"Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab. 1971;33(1):14\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2541_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000013380","volume":"18","author":"WH Bay","year":"1998","unstructured":"Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol. 1998;18(5):379\u201383.","journal-title":"Am J Nephrol"},{"issue":"3","key":"2541_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2702.2004.01036.x","volume":"14","author":"B Hagren","year":"2005","unstructured":"Hagren B, Pettersen IM, Severinsson E, L\u00fctz\u00e9n K, Clyne N. Maintenance haemodialysis: patients' experiences of their life situation. J Clin Nurs. 2005;14(3):294\u2013300.","journal-title":"J Clin Nurs"},{"key":"2541_CR16","first-page":"1195","volume":"74","author":"KA Deck","year":"1968","unstructured":"Deck KA, Siemon G, Sieberth HG, von Bayer H. Cortisol loss and plasma 11-hydroxy-corticosteroid profile during hemodialysis. Verh Dtsch Ges Inn Med. 1968;74:1195\u20138.","journal-title":"Verh Dtsch Ges Inn Med"},{"issue":"20","key":"2541_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/BF01487134","volume":"48","author":"E Knapp","year":"1970","unstructured":"Knapp E, Staudinger E, Dittrich P. Behavior of free plasma cortisol during extracorporeal hemodialysis. Klin Wochenschr. 1970;48(20):1243\u20134.","journal-title":"Klin Wochenschr"},{"issue":"1","key":"2541_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1210\/jcem-50-1-46","volume":"50","author":"EZ Wallace","year":"1980","unstructured":"Wallace EZ, Rosman P, Toshav N, Sacerdote A, Balthazar A. Pituitary-adrenocortical function in chronic renal failure: studies of episodic secretion of cortisol and dexamethasone suppressibility. J Clin Endocrinol Metab. 1980;50(1):46\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2541_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1210\/jcem-45-4-818","volume":"45","author":"K Shimamoto","year":"1977","unstructured":"Shimamoto K, Ando T, Nakao T, Watarai I, Miyahara M. Permeability of antidiuretic hormone and other hormones through the dialysis membrane in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab. 1977;45(4):818\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2541_CR20","first-page":"1258","volume":"290","author":"GL Barbour","year":"1974","unstructured":"Barbour GL, Sevier BR. Letter: adrenal responsiveness in chronic hemodialysis. N Engl J Med. 1974;290(22):1258.","journal-title":"N Engl J Med"},{"issue":"3","key":"2541_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2362.1979.tb00924.x","volume":"9","author":"KA Deck","year":"1979","unstructured":"Deck KA, Fischer B, Hillen H. Studies on cortisol metabolism during haemodialysis in man. Eur J Clin Investig. 1979;9(3):203\u20137.","journal-title":"Eur J Clin Investig"},{"issue":"5","key":"2541_CR22","first-page":"629","volume":"17","author":"L Vigna","year":"1995","unstructured":"Vigna L, Buccianti G, Orsatti A, Cresseri D, Bianchi ML, Cremagnani L, et al. The impact of long-term hemodialysis on pituitary-adrenocortical function. Ren Fail. 1995;17(5):629\u201337.","journal-title":"Ren Fail"},{"issue":"11","key":"2541_CR23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/BF01709332","volume":"22","author":"T Tsubo","year":"1996","unstructured":"Tsubo T, Hashimoto Y, Araki I, Ishihara H, Matsuki A. Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome. Intensive Care Med. 1996;22(11):1176\u20138.","journal-title":"Intensive Care Med"},{"issue":"14","key":"2541_CR24","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2169\/internalmedicine.53.1104","volume":"53","author":"Y Sakao","year":"2014","unstructured":"Sakao Y, Sugiura T, Tsuji T, Ohashi N, Yasuda H, Fujigaki Y, et al. Clinical manifestation of hypercalcemia caused by adrenal insufficiency in hemodialysis patients: a case-series study. Intern Med. 2014;53(14):1485\u201390.","journal-title":"Intern Med"},{"issue":"3","key":"2541_CR25","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1111\/hdi.12412","volume":"20","author":"TJ Koh","year":"2016","unstructured":"Koh TJ, Chan CT. Adrenal insufficiency presenting as unexplained hypotension in nocturnal home hemodialysis. Hemodial Int. 2016;20(3):E10\u20133.","journal-title":"Hemodial Int"},{"key":"2541_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00002480-197700230-00190","volume":"23","author":"M Akmal","year":"1977","unstructured":"Akmal M, Manzler AD. Simplified assessment of pituitary-adrenal axis in a stable group of chronic hemodialysis patients. Trans Am Soc Artif Intern Organs. 1977;23:703\u20136.","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"8","key":"2541_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/archinte.1982.00340210040010","volume":"142","author":"G Ramirez","year":"1982","unstructured":"Ramirez G, Gomez-Sanchez C, Meikle WA, Jubiz W. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med. 1982;142(8):1448\u201352.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2541_CR28","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1210\/jcem-61-6-1205","volume":"61","author":"PG Zager","year":"1985","unstructured":"Zager PG, Spalding CT, Frey HJ, Brittenham MC. Low dose adrenocorticotropin infusion in continuous ambulatory peritoneal dialysis patients. J Clin Endocrinol Metab. 1985;61(6):1205\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2541_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000181019","volume":"30","author":"KC Siamopoulos","year":"1988","unstructured":"Siamopoulos KC, Eleftheriades EG, Pappas M, Sferopoulos G, Tsolas O. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses. Horm Res. 1988;30(1):17\u201321.","journal-title":"Horm Res"},{"issue":"1\u20132","key":"2541_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000182100","volume":"36","author":"B Watschinger","year":"1991","unstructured":"Watschinger B, Watzinger U, Templ H, Spona J, Graf H, Luger A. Effect of recombinant human erythropoietin on anterior pituitary function in patients on chronic hemodialysis. Horm Res. 1991;36(1\u20132):22\u20136.","journal-title":"Horm Res"},{"issue":"4","key":"2541_CR31","first-page":"307","volume":"8","author":"AC Grant","year":"1993","unstructured":"Grant AC, Rodger RS, Mitchell R, Gibson S, White A, Robertson WR. Hypothalamo-pituitary-adrenal axis in uraemia: evidence for primary adrenal dysfunction? Nephrology Dial Transpl. 1993;8(4):307\u201310.","journal-title":"Nephrology Dial Transpl"},{"issue":"1","key":"2541_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/ajkd.1998.v32.pm9669424","volume":"32","author":"M Clodi","year":"1998","unstructured":"Clodi M, Riedl M, Schmaldienst S, Vychytil A, Kotzmann H, Kaider A, et al. Adrenal function in patients with chronic renal failure. Am J Kidney Dis. 1998;32(1):52\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2541_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF03347016","volume":"26","author":"Y Oguz","year":"2003","unstructured":"Oguz Y, Oktenli C, Ozata M, Ozgurtas T, Sanisoglu Y, Yenicesu M, et al. The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease. J Endocrinol Investig. 2003;26(7):609\u201315.","journal-title":"J Endocrinol Investig"},{"issue":"7414","key":"2541_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ."},{"issue":"7109","key":"2541_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ."},{"issue":"4","key":"2541_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000183254","volume":"37","author":"PM Rosman","year":"1984","unstructured":"Rosman PM, Benn R, Kay M, Wallace EZ. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin. Nephron. 1984;37(4):229\u201331.","journal-title":"Nephron."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02541-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T16:05:24Z","timestamp":1635782724000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02541-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02541-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CAB has received travel funding from Novo Nordisk and participated in an advisory board meeting for Tolvaptan for Otsuka Pharmaceutical Switzerland, in 2019. All other authors report no conflicts of interest.The results presented in this paper have not been published previously in whole or part.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}